Because PRMT5-driven methylation of arginine residues leads to H4R3me2s and H3R8me2s, we then measured H4R3me2s and H3R8me2s in HCC cells treated with si-PRMT5. The gene discussed is PRMT5; the disease is hepatocellular carcinoma.